Cargando…
Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer
Triple-negative breast cancer (TNBC) currently lacks a suitable therapeutic candidate and is thus difficult to treat. Here, we report that a cationic antimicrobial peptide (CAP), tilapia piscidin 4 (TP4), which was derived from Nile tilapia (Oreochromis niloticus), is selectively toxic to TNBC. TP4...
Autores principales: | Ting, Chen-Hung, Chen, Yi-Chun, Wu, Chang-Jer, Chen, Jyh-Yih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130011/ https://www.ncbi.nlm.nih.gov/pubmed/27248170 http://dx.doi.org/10.18632/oncotarget.9612 |
Ejemplares similares
-
Antimicrobial Peptide TP4 Targets Mitochondrial Adenine Nucleotide Translocator 2
por: Su, Bor-Chyuan, et al.
Publicado: (2020) -
Nile Tilapia Derived Antimicrobial Peptide TP4 Exerts Antineoplastic Activity Through Microtubule Disruption
por: Ting, Chen-Hung, et al.
Publicado: (2018) -
FOSB–PCDHB13 Axis Disrupts the Microtubule Network in Non-Small Cell Lung Cancer
por: Ting, Chen-Hung, et al.
Publicado: (2019) -
Efficacy of the antimicrobial peptide TP4 against Helicobacter pylori infection: in vitro membrane perturbation via micellization and in vivo suppression of host immune responses in a mouse model
por: Narayana, Jayaram Lakshmaiah, et al.
Publicado: (2015) -
EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress
por: Zhang, Ruishan, et al.
Publicado: (2020)